Shen, Yang, Xianwen Chen, Hao Zhang, and Hao Hu. 2024. “Long-Term Cost-Effectiveness Analysis of onceweekly Semaglutide Versus Dulaglutide for the Treatment of Type 2 Diabetes After the Renewal of the National Drug Reimbursement List in China”. Health Decision 2 (S1). https://doi.org/10.54844/hd.2024.0003.